Drug intelligence / Profile preview

Bcann ASD

Development stage: Preclinical
Lead developer: Bazelet Group
Modality: Classical Binding Small Molecules → Small Molecules
Administration: Oral, Sublingual

Overview

Bcann ASD is a terpenes-enriched medical cannabis formulation developed by Bazelet Group specifically for the treatment of epilepsy and autism spectrum disorder (ASD) in pediatric populations. The formulation utilizes a proprietary blend of cannabinoids and specific terpenes designed to modulate the endocannabinoid system, aiming to reduce symptoms such as seizure frequency and behavioral challenges. By enriching the cannabis extract with specific terpenes, the product seeks to enhance the therapeutic entourage effect while potentially improving the safety profile for children. Clinical development for pediatric epilepsy is conducted in collaboration with the Schneider Children's Medical Center of Israel.

Brand names: Bcann ASD
Other names: Bcann-Bazelet Group-cannabis formulation (terpenes-enriched)-epilepsy-autism (pediatric/children)Bazelet ASD formulationTerpenes-enriched cannabis formulation for pediatric epilepsy and autism

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Bcann ASD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bcann ASD.

Explore the full profile